that are thought to reflect a failed attempt at elongation (Ramon y Cajal, 1928; Schwab and Bartholdi, 1996).
AB2.2 ES cells (Figure 1G
. Chimeric mice were generTo clarify the role of Nogo in inhibition of axon regenerated and bred to C57BL/6 females. Three independently ation in vivo and the domains important for inhibition, targeted ES cell clones gave germline transmission. Inwe generated mice that either lack Nogo-A and -B (but tercrosses between heterozygous mutants gave rise to not -C) or that carry a C-terminal mutation that disrupts 49 wild-type, 90 heterozygous, and only 1 homozygous all three isoforms, and we assessed the regenerative pup, indicating embryonic lethality of most homozygous response of CNS axons to spinal cord injuries. Our remutants. This lethality does not appear to be caused by sults reveal no evidence for enhanced regeneration in the neomycin resistance gene, including its PGK prothese animals.
moter, since excision of this marker gene with a Cre deleter mouse (Lewandoski et al., 1997) failed to rescue the lethality (10 ϩ/ϩ, 31 ϩ/m, and 0 m/m out of 6 litters Results from intercrosses between heterozygotes). We did not determine the age at which lethality occurs, but assume Generation of Nogo-A/B Mutant Mice Figure 1A shows the structure of the nogo gene, asit is before embryonic day 9.5 (E9.5), since no homozygous mutants were recovered at that stage (16 embryos sessed by characterizing genomic clones isolated from a mouse 129S5 genomic library and through analysis scored from 2 litters). Because the Nogo-A/B mutant was viable, these reof genomic sequence from databases. The nogo gene spans over 50 kB and contains an A/B-specific exon sults initially suggested that the C-isoform is required for viability. However, the single viable homozygous (exon 1), two A-specific exons, one C-specific exon, and six A/B/C common exons.
Nogo-A/B/C mutant we obtained (the escaper, see above) proved fertile, and from it we were able to derive To address the role of the long amino-terminal extension of Nogo, we generated a Nogo N-terminal mutation a line of mice in which homozygosing the mutation no longer resulted in lethality (see Experimental Procedures in which the A and B isoforms are specifically mutated, and only the C isoform remains. This mutation deletes an for details). In fact, the homozygous mutants were fertile and could be maintained as a line. Southern blot analysis amino-terminal genomic fragment including the entire coding region of exon 1 downstream of the ATG start of these animals showed that the gene targeting event in the original ES cell line was apparently unaffected codon ( Figure 1B ) and is expected to completely abolish Nogo-A and Nogo-B expression. The targeted allele was (data not shown). Northern analysis did not detect any Nogo-A or -B isoform transcripts, presumably reflecting obtained in AB2.2 ES cells (derived from strain 129S7) ( Figure 1C) , which was then used to generate chimeric their destabilization ( Figure 1H) . A lower level of a nogo transcript that is slightly smaller than the wild-type mice. Heterozygous mutants were obtained by breeding chimeric mice to C57BL/6 females, and the mutation nogo-C transcript was observed, which is as predicted for the mutated nogo-C transcript (also destabilized but was backcrossed to C57BL/6 one more time before being homozygosed. In intercrosses between (C57BL/6 ϫ still present) and is expected to produce no functional protein. Indeed, RT-PCR and sequence analysis con-129S7) N2 heterozygotes, wild-type, heterozygous, and homozygous progeny appeared in Mendelian ratios firmed that this transcript results from splicing over the neomycin cassette and, if translated, will produce a (10 ϩ/ϩ, 22 ϩ/m, and 10 m/m out of 5 litters). Homozygous mutants were viable, fertile, and morphologically short peptide with the first 11 amino acid residues identical to those in wild-type Nogo-C but with the next 25 indistinguishable from their wild-type littermates. Northern blot analysis of brain tissue from adult homozygous residues translated in a shifted frame ( Figure 1I and data not shown); importantly, the 66 amino acids in the lumenal/extracellular loop will be absent. Western analysis of whole brain extract using the anti-Nogo-A antibody demonstrated the absence of the A isoform ( Figure  1J ), as did immunostaining with the same antibody in the adult spinal cord (data not shown). We therefore conclude that the Nogo-A/B/C mutant likely represents a null mutant for Nogo-C and a null or severe hypomorph for Nogo-A and -B. The serendipitous derivation of this viable Nogo C-terminal mutant allowed us to assess whether regeneration is enhanced in the absence not just of the A and B isoforms but also of Nogo-C. It is not immediately clear how an escaper line could arise from the otherwise lethal Nogo C-terminal mutation. An insight was, however, obtained when we generated two more nogo mutant alleles (B.Z., M.T.-L., unpublished observations). First, we obtained a doubly targeted allele in which both the N-terminal and the C-terminal region of nogo were targeted in cis (i.e., the two targeted events occurred on the same chromosome). Surprisingly, this line of mice (Nogo N/C-terminal doubly targeted allele) was homozygous viable and fertile, indicating that the targeting event at the N terminus of nogo rescues the lethality associated with the C-terminal mutation. Second, we generated a nogo deletion allele, with the genomic region between the A,B-specific exon and the first common exon deleted by Cre-mediated excision of the doubly targeted line. This allele is expected to be completely devoid of any known Nogo isoforms and almost certainly represents a clean null allele. It also proved viable and fertile (see Supplemental  Table S1 at http://www.neuron.org/cgi/content/full/38/ 2/213/DC1). These results argue against an essential croscissors followed by a microknife, or (2) using a 30 gauge needle to puncture the dura, followed by a microknife. These lesions resulted in the transection of the main corticospinal tracts (located in the ventral portion of the dorsal columns), as well as the lateral corticospinal tracts (sparse fibers located dorso-laterally within the white matter surrounding the spinal cord). To visualize the descending corticospinal tract axons, the tracer biotinylated dextran amine (BDA) was injected into the sensorimotor cortex at the time of the injury. In the first cohort of animals studied (five wild-type, three heterozygous, and eight homozygous mutants), BDA was injected into the cortex bilaterally. In subsequent experiments, injections were performed unilaterally to help examine whether regenerative sprouting occurred across the midline. To assess axonal regeneration, animals were sacrificed 14-19 days after injury for histological analysis, to maximize chances for detecting early stages of regeneration. Spinal cord segments either 1 or 2.5 cm long, with the lesion site approximately in the center, were sectioned in the sagittal plane (25 m sections). All sections were collected in serial order so that individual labeled axons could be traced from section to section, allowing reconstruction of the axonal projections. In animals where only a 1 cm block was taken, additional 3 mm blocks 0.5 cm rostral and 0.5 cm caudal to the 1 cm block were sectioned in the transverse plane. There was no systematic difference between mutant and control animals in the appearance of the lesions, although the extent varied somewhat from animal to animal. In most, lesions were as designed (i.e., they completely transected the dorsal half of the spinal cord and extended beyond the central canal, and so strictly speaking should be characterized as "dorsal over-hemisections"). Macrophages accumulated in the lesion site to a variable extent, as assessed in tissue sections (data not shown). In many animals, a dense network of presumed fibroblastic tissue was noted at the lesion site (e.g., Figures 3A and 3B ).
There was no indication of a greater degree of regeneration or sprouting in the Nogo-A/B mutant animals. Indeed, we did not detect any difference in the distribution of labeled CST axons between mutants and controls. Thus, the following description applies to both, as tion. These fine labeled axons were seen in both Nogo-A/B mutant and control animals ( Figures 3E and 3F) . In (mutants and controls) was an abrupt end to labeled axons at the lesion site except for the fine branches that a few animals of each genotype, one to three axons were observed in the distal segment below the injury projected from the distal portion of the main CST into the adjacent gray matter. Axons in the gray matter likely site; the number and distribution was similar in mutants and controls ( Figure 3I) . represent mostly normal collateral branches to that segment, although we cannot exclude that some are regenTo assess whether subtle differences might be present, quantification of fibers in a subset of animals was erative sprouts. In any case, there was no systematic difference between Nogo-A/B mutant and control aniundertaken. These animals were selected in a blinded manner for quantification based on the following criteria: mals in the extent of these collaterals. This description excluded four animals. In three of (1) staining was of uniform high quality, (2) all sagittal sections were recovered, (3) no obviously spared main them, two wild-type and one mutant, a large cohort of labeled axons could be seen in the dorsal funiculus CST axons were observed, (4) the lesion site could be defined, and (5) medullary sections of high quality were caudal to the lesion. These axons almost certainly were spared by the lesion, probably by being pushed aside obtained for normalization of tracing. Seven wild-type and eight mutant animals satisfied these criteria. The as it was made, based on their length (several millimeters below the lesion), appearance (straight and unbranched), quantification method is described in Experimental Procedures. Briefly, the numbers of fibers running outside and location (in the normal position of the tract). In the fourth animal, a wild-type, we were surprised to observe the main dorsomedial CST at different rostrocaudal levels from the lesion site were analyzed using a light microwhat at first appeared to be a population of labeled axons diffusely distributed in the lateral column ipsilatscope. In each animal, labeled axons were counted at multiple designated rostrocaudal levels in the sagittal eral to the main labeled tract, in transverse sections rostral and caudal to the lesion site (see Supplemental sections running through the main CST and sections adjacent to it. To correct for interanimal tracing variabil- Figure S2A at http://www.neuron.org/cgi/content/full/ 38/2/213/DC1) as well as in the sagittal sections through ity, the numbers of counted axons in each animal were normalized to the numbers of BDA-positive CST fibers the lesion site (data not shown). Closer inspection revealed unusual features of these profiles: when the secin the medullary pyramid rostral to the pyramidal decussation. Quantification was performed in a blinded mantions were viewed using dark field illumination, all other labeled axons reflected light but these profiles did not ner. There was no significant difference between mutants and wild-type animals in the numbers of fibers at (Supplemental Figures S2B and S2C) , and at high magnification they appeared thicker and had a "hollow" apany level ( Figure 3I Figures 4B, 4D, 4F , (see Supplemental Figure S3A at http://www.neuron. org/cgi/content/full/38/2/213/DC1), but there was no and 4H). In many animals, a number of labeled axons crossed the midline to enter the gray matter on the side statistically significant difference between the mutants and wild-type animals in the degree of functional recontralateral to the labeled main tract (that is, ipsilateral to the injection; see especially Figures 4J and 4L) . In covery.
The absence of regeneration in these animals consome animals, there were also a few labeled axons in the dorsal column on the side ipsilateral to the injection trasts with the apparently extensive regeneration observed by Dr. S. Strittmatter and colleagues in a different (e.g., arrowheads in Figures 4F and 4H) . Although there was animal to animal variability, there was no systematic Nogo mutant mouse line (personal communication; see Discussion). We were concerned that the difference in difference between Nogo-A/B mutant and control mice. While there was heavy labeling of the CST above the these two studies could reflect a difference in the method of producing the lesion. To address this directly, level of the injury (Figures 4A-4H Figures 3C and 3D , respectively. (E) and (I) are from the same wild-type animal; (G) and (K) are from the same mutant animal. Scale bar equals 300 m. and controls. The CST ended abruptly just rostral to the isoforms, could cause greater regeneration than that lesion site in characteristic retraction bulbs (Figures 5A seen in our Nogo-A/B mutant animals. We performed
. Distribution of Corticospinal Fibers on Transverse Sections in Segments Rostral and Caudal to the Injury in Nogo-A/B Mutant and Control Mice (A), (C), (E), (G), (I), and (K) are transverse sections of the spinal cord taken from about 0.5 cm rostral (A, C, E, and G) or 0.5 cm caudal (I and K) to the injury site of representative wild-type (A, E, and I) and Nogo-A/B mutant (C, G, and K) mice, which received unilateral tracer injection. Animals shown in (A) and (C) correspond to those shown in

(B), (D), (F), (H), (J), and (L) are high-magnification images of the boxed areas in (A), (C), (E), and (G). Open arrows in (A)-(H) indicate the labeled main CST (in the ventral part of the dorsal column on the left hand side). (B), (D), (F), and (H) show the heavily labeled main CST (open arrows
and 5B). A few axon collaterals could be seen just rostral spinal cord lesions in Nogo-A/B/C mutant mice obtained to the terminal end bulbs, and these extended down from breeding the one initial escaper, and we examined into the underlying gray matter (Figures 5A and 5B) . the corticospinal projection for regeneration. For this Evaluation of transverse sections from mutant and experiment, animals were allowed to survive for longer control animals revealed heavy labeling of the CST periods following the spinal cord injury (9 weeks) in case above the level of the injury; again, hundreds of labeled the failure to detect regeneration was due to the short axons entered the segment rostral to the injury (for expostinjury survival period. Thus, animals received bilatamples, see Figures 5C and 5D ). At the same time, in eral BDA injections 7 weeks after the spinal cord injury all animals but one there were no labeled axons below (and 2 weeks prior to being sacrificed). Eight wild-type the level of the injury (Figures 5E and 5F ). In the one and eight mutant animals that survived the procedure were analyzed. exceptional case (Figure 5F ), which was a mutant, we Figure 5F ). We were not able to trace this axon through more rostral segments, sufficient to permit significant regeneration in vivo, presumably either because Nogo's in vitro activity does not and so we were unable to define its course to determine whether it was spared or had regenerated. spinal tract, although it is uncertain whether this is true in adult animals or only in young ones (personal commuIt is possible that only a subpopulation of CST axons regenerated, and that we failed to label that population. nication). It is difficult to account for the remarkable divergence This seems unlikely, given the extent of labeling in our studies. (2) The specific surgical paradigm we used may between our study and theirs. We studied both young and old animals (the median age was young [8 weeks]), have made regeneration more difficult. This again seems unlikely, since the techniques used were similar (if not but we saw no regeneration or enhanced sprouting. We do not believe that differences in surgical or labeling identical) and since no regeneration was observed in our Nogo-A/B mutants when they were lesioned by Dr.
did detect a single labeled axon in the caudal segment confirming that Nogo-A/B contributes to inhibition in vitro-our results imply that loss of Nogo-A/B is not (see high-magnification inset in
techniques can explain the difference, since similar techniques were used by both groups and since Dr. S. Li using a protocol that apparently allowed regeneration in a line of mice analyzed by him in Dr. Strittmatter's Strittmatter reports extensive sprouting far rostral to the lesion, which should be insensitive to the precise lesion laboratory. (3) Our studies were performed in mice, whereas the antibody treatment studies were performed techniques that are used. We are thus left with three possible explanations for in rats. It is conceivable that more regeneration could be observed in a different species or in a different genetic the discrepancy. The first is differences in genetic backgrounds; however, if this is the explanation, it again background (ours was mixed, about three-quarters C57BL/6 and one-quarter 129S7). (4) The antibody treatcalls into question the robustness of regeneration that is possible following loss of Nogo function. The second ment was acute, whereas our genetic deletion was present through development. It is conceivable that compenis that in our mutant, but not Dr. Strittmatter's, some compensatory change occurred that suppressed regensatory changes occurred in the mutant mice that diminished regenerative capacity. (5) We also consideration. The third is that Dr. Strittmatter's phenotype reflects more than a loss of Nogo function. The mutation ered the possibility that the absence of a regenerative response in Nogo-A/B mutants might be due to the they analyzed was generated by Lexicon Genetics by random insertion of a complex gene trap vector conpresence of the Nogo-C isoform (although the antibody targeted Nogo-A specifically). We therefore generated taining a strong promoter (Zambrowicz et al., 1998), and it is possible that this has resulted in alteration mice in which all three isoforms are mutated through targeting of the C-terminal common region. Although or deregulation of other neighboring genetic loci, with regeneration being caused secondarily by this change. we initially found that these mutants are embryonic lethal, we did obtain one viable homozygous mouse from Second, Dr. M. Schwab and colleagues ( shaved and swabbed with Betadine. A midline incision was made over the thoracic vertebrae, the paravertebral muscles were sepatargeted clones were identified.
To target the Nogo C-terminal region to generate Nogo-A/B/C rated from the vertebral column and retracted, and a laminectomy was performed at the desired level (T7-8). Dorsal hemisection injurmutants, a replacement vector was constructed with a floxed neomycin resistance gene as the positive selection marker and HSVTK ies were produced in one of two ways. For the experiments involving Nogo-A/B/C mutants and their littermate controls, a fine microknife as the negative selection marker. The two loxP sites in this vector are in the same orientation as the one in the N-terminal targeting was lowered 0.7 mm into the cord near the midline to the level of the central canal. The microknife was then drawn across the dorsal vector described above when targeted at the nogo locus, so that a deletion can be made from a doubly targeted allele with Cre-mediaspect of the spinal cord through the dura. The procedure was then repeated going in the opposite direction. For the experiments ated excision. A 1.9 kb SacI-HindIII genomic fragment containing the first common exon was deleted. A 1.5 kb 5Ј external probe was involving the Nogo-A/B mutant animals and their controls, the dorsal spinal cord was first either cut with a pair of microscissors, or the used to detect targeted ES cell clones. Among 180 ES cell clones screened by Southern blot, 12 targeted clones were identified. Hetdura was punctured with a 30 gauge needle bilaterally on the lateral aspects of the cord; in either case, this was followed by drawing a erozygous Nogo-A/B/C mutant mice were derived from three of these ES cell lines. As described in the text, intercrosses of these fine microknife through the dorsal spinal cord to assure complete hemisection. After hemostasis was achieved, the muscle layers and mice generally failed to yield any viable homozygous progeny, except for a single escaper-a homozygous male pup that grew to the skin were sutured.
